NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Arbor Realty Trust (ABR) upgraded to hold at TheStreet ratings.
Allergan (AGN) rated new Hold at Canaccord. Valuation call, based on a $101 price target.
Baxter (BAX) rated new Outperform at BMO. $70 price target. Company has a solid pipeline and can deliver consistent, long-term growth.A.M. Castle (CAS) upgraded to hold at TheStreet ratings. Clean Energy (CLNE) rated new Hold at Keybanc. Company lacks potential near-term catalysts. CSX (CSX) downgraded at UBS to Neutral from Buy, UBS said. $24.50 price target. Catalyst lacking and Q3 estimates falling. Dover (DOV) rated new Buy at Capstone. $71 price target. Company is focused on targeted growth areas. FMC (FMC) rated new Neutral at Goldman. Valuation call, based on a $62 price target. Corning (GLW) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $16 price target. LCD glass cycle appears to be bottoming and the company is cutting back on capital spending. Hasbro (HAS) downgraded at Needham from Buy to Hold, Needham said. Valuation call. Kansas City Southern (KSU) downgraded at UBS to Sell from Neutral, UBS said. $74 price target. Lack of catalyst and trades at premium to peers. Lam Research (LRCX) downgraded at Citigroup to Neutral from Buy, Citigroup said. $34 price target. Apple's shift to TSMC from Samsung could be negative. Marathon Oil (MRO) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $37 price target. Estimates also boosted, as the Paloma acquisition should add to earnings. Norfolk Southern (NSC) downgraded at UBS to Neutral from Buy, UBS said. $79 price target. Valuation trap lacking compelling investment case. Northern Trust (NTRS) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. Valuation call, based $40 price target. Charles Schwab (SCHW) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company is leveraged to lower RMBS yields. $14 price target. St. Jude (STJ) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. ICD market is stabilizing and the company should benefit from a weaker dollar. Union Pacific (UNP) downgraded at UBS to Neutral from Buy, UBS said. $135 price target. Premium valuation moves us to sidelines.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV